In a recent New England Journal of Medicine perspective piece, Harvard Medical School's Aaron Kesselheim and Rahul Rajkumar discuss ownership of federally funded research in the context of the Bayh-Dole Act, particularly related to what they call the "long-simmering dispute between Stanford University and Roche Molecular Systems regarding ownership of a widely used and profitable diagnostic assay for human immunodeficiency virus." Kesselheim and Rajkumar suggest that the US Supreme Court's decision — th